Relevant Publications

  1. Peters MJL, Symmons DPM, McCarey DW, Nurmohamed MT, on behalf of the EULAR task force ‘Cardiovascular Risk Management in RA’. Cardiovascular risk management (CV-RM) in patients with rheumatoid arthritis and other types of inflammatory arthritis. Ann Rheum Dis september 22. 2009; doi:101136/ard.2009.113696
  2. AG Semb, Sella Provan,Tore K Kvien. Terje R Pedersen. Effect of high intensity statin treatment in rheumatoid arthritis. A case with possible coronary atheroma regression and progression of rheumatoid valve degeneration. BMJ 2009; doi: 10. 1136/brc.08.0717
  3. AG Semb, T K Kvien, A H Aastveit, I Jungner, T R Pedersen, G Walldius, I Holme. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis 2010. doi: 10.1136/ard.2009.126128, Ann Rheum Dis. 2011;70(5):812-7
  4. Anne Grete Semb, Ingar Holme, Sella Provan,Tore K Kvien. Terje R Pedersen. Intensitive lipid lowering in patients with Rheumatoid Arthritis and previous myocardial infarction: an explorative analysis in the IDEAL trial. Rheumatology (oxford) Rheumatology (Oxford). 2011 Feb;50(2):324-9. Epub 2010 Sep 30.
  5. Sella Aarrestad Provan, Kristin Angel, Anne Grete Semb, Dan Atar, Tore Kristian Kvien. NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from a 10-year follow-up of the EURIDISS study. Ann Rheum Dis 2010; 69(11):1946-50
  6. Sella Provan, Anne Grete Semb, Johnny Hisdahl, Einar Stranden,Hanne Dafinnrud, Kristin Angel, Dan Atar, Tore K. Kvien. Remission is the mission in cardiovascular disease prevention:A cross-sectional controlled study of CVD risk markers in Rheumatoid Arthritis. Ann Rheum Dis. 2011 May;70(5):812-7. Epub 2011 Feb 2
  7. Sella Provan , Kristin Angel, Anne Grete Semb, Dan Atar & Tore K. Kvien. Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis.J Rheumatol. 2011 Apr;38(4):606-12. Epub 2011 Jan 15.
  8. Silje Halvorsen, Nina K. Vøllestad, Camilla Fongen, Sella A. Provan, Anne G. Semb, Kåre B. Hagen, Hanne Dagfinrud. Physical fitness in patients with ankylosing spondylitis. A comparison with population controls. Phys. Ther. 2012;92(2):298-309
  9. Anne Grete Semb, Tore K Kvien, Rana Fayyad, Chuan-Chuan Wun, Terje R Pedersen, Ingar Holme. Effect of intensive lipid lowering on cardioascular outcome in patients with and without inflammatory joint disease. Arthritis and Rheumatism 2012 May doi: 10.1002/art.34524
  10. Anne Grete Semb, Tore K Kvien, Rana Fayyad, Chuan-Chuan Wun, Terje R Pedersen, Ingar Holme. Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: The role of lipoproteins in a high risk population J Rheumatology 2012; 39: (7):1433-40
  11. Silvia Rollefstad, Tore K Kvien, Ingar Holme, Anne S Eirheim,Terje R Pedersen, Anne Grete P Semb. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Ann Rheum Dis Online First, Dec 22, 2012 as 10.1136/annrheumdis-2012-202789
  12. AG Semb, S Rollefstad, S Provan, H Dagfinrud, I. Holme. TK Kvien. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol 2013;40;359-368
  13. S. Halvorsen, N.K. Vøllestad, S.A. Provan, A.G. Semb, van der Heijde D, K.B. Hagen, H. Dagfinrud. Cardiorespiratory fitness and cardiovascular risk profile in patients with ankylosing spondylitis. A comparison with population controls. Arthritis Care Res 2013; 65(6): 969-76
  14. Maehlen MT, Provan SA, de Rooy DP, van der Helm-van Mil AH, Krabben A, Saxne T, Lindqvist E, Semb AG, Uhlig T, van der Heijde D, Mero IL, Olsen IC, Kvien TK, Lie BA. Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis.PLoS One. 2013 Apr 17;8(4):e60970. doi: 10.1371/journal.pone.0060970.
  15. Dessein PH, Semb AG. Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? Editorial Ann Rheum Dis 2013 2013; 72(11):1743-6
  16. N Østerås, MA Risberg, TK Kvien, L Engebretsen, L Nordsletten, D Bruusgaard, U-B Schjervheim, I K Haugen, HB Hammer, S Provan, BE Øiestad, AG Semb, S Rollefstad, KB Hagen, T Uhlig, B Slatkowsky-Christensen, I Kjeken, G Flugsrud, M Grotle, S Sesseng, H Edvardsen, B Natvig. Hand, hip and knee osteoarthritis in a Norwegian population-based study – The MUST protocol. BMC Musculoskeletal Disorders 2013, 14:201 doi:10.1186/1471-2474-14-201
  17. Arts E, Popa C, Den Broeder AA, Semb AG, Kitas G, van Riel P, Fransen J. Predicting the risk of cardiovascular disease in rheumatoid arthritis patients with five currently used risk alagorithms.Ann Rheum Dis 2014 (January 1.) online doi:10.1136/annrheumdis-2013-204024
  18. AG Semb, S Rollefstad, P van Riel, GD Kitas, EL Matteson, SE Gabriel.Cardiovascular Disease Assessment in Rheumatoid Arthritis: A guide to translating knowledge of cardiovascular risk into clinical practice. Ann Rheum Dis 2014 10.1136/annrheumdis-2013-204792
  19. S Rollefstad, E Ikdahl, I Holme, J Hisdal, TK Kvien, TR Pedersen, AG Semb. Systemic inflammation in patients with inflammatory joint disease does not influence statin dose needed to obtain LDL-c goals in cardiovascular prevention. Anne Rheum Dis 2014 10.1136/annrheumdis-2013-204636
  20. A.G. Semb, S. Rollefstad, S. Provan, A. Eirheim, I. Olsen, E. Stranden, J. Hisdal, D. van der Heijde, T.K. Kvien, T.R. Pedersen. Ultrasound of carotid arteries enhances correct cardiovascular risk evaluation in patients with inflammatory joint diseases. Rheumatology (in press)
  21. Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors, and the impact of treatment. J Rheumatol 2014 (in press)